CETUXIMAB

cetuximab 100 mg/20 mL injection, 20 mL vial

CETUXIMAB (7223E)

7223E
Body System:
Manner of administration:Injection
Private
Chemotherapy Items for Private Hospital use
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 4794)

Indication: Stage III, IVa or IVb squamous cell cancer of the larynx, oropharynx or hypopharynx
Treatment phase: Initial treatment

Restriction (Streamlined authority code: 4785)

Indication: Stage III, IVa or IVb squamous cell cancer of the larynx, oropharynx or hypopharynx
Treatment phase: Initial treatment
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 880 mg # of repeats: 0 DPMA: $2,587.48 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Erbitux
(cetuximab 100 mg/20 mL injection, 20 mL vial)
Erbitux
(cetuximab 500 mg/100 mL injection, 100 mL vial)